Silexion Therapeutics prices $5.0M public offering at $1.35 per share

Silexion Therapeutics (SLXN) announced the pricing of a public offering of an aggregate of 3,703,703 of the Company’s ordinary shares and warrants to purchase up to 3,703,703 ordinary shares at a combined public offering price of $1.35 per share and accompanying warrant. The warrants will have an exercise price of $1.35 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance. The closing of the offering is expected to occur on or about January 17, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.